Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Pluristem Ltd.
ClinicalTrials.gov Identifier:
NCT01679990
First received: September 2, 2012
Last updated: January 20, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)